ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call Transcript May 15, 2023
ReShape Lifesciences Inc. beats earnings expectations. Reported EPS is $21, expectations were $-4.21.
Operator: Good afternoon, and thank you for joining the ReShape Lifesciences First Quarter 2023 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications.
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences first quarter 2023 earnings call....
